153 related articles for article (PubMed ID: 232302)
1. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
Homenko AG; Ciukanov VL
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
[TBL] [Abstract][Full Text] [Related]
2. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
[No Abstract] [Full Text] [Related]
3. [Principles of rational tuberculosis chemotherapy].
Khomenko AG
Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466
[TBL] [Abstract][Full Text] [Related]
4. [A new therapeutic approach to open pulmonary tuberculosis with a combination of isoniazid, prothionamid and dapson (author's transl)].
González Montaner LF; Garay C; Abbate EH; Albareda MA
Prax Klin Pneumol; 1978 Jul; 32(7):488-90. PubMed ID: 98759
[No Abstract] [Full Text] [Related]
5. [Long-term treatment of tuberculosis with isoprodian (author's transl)].
Bergsmann O; Spielmann E
Wien Klin Wochenschr; 1979 Aug; 91(15):513-6. PubMed ID: 473771
[TBL] [Abstract][Full Text] [Related]
6. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
Sighart H; Opl G; Weirich H
Wien Med Wochenschr; 1982 Nov; 132(22):559-61. PubMed ID: 7168180
[No Abstract] [Full Text] [Related]
8. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
[TBL] [Abstract][Full Text] [Related]
9. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
Opl G; Benkö M
Prax Pneumol; 1977 Feb; 31(2):116-20. PubMed ID: 846937
[No Abstract] [Full Text] [Related]
11. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
12. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
Masztalerz J
Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
[No Abstract] [Full Text] [Related]
13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
14. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of open cavernous pulmonary tuberculosis (author's transl)].
Kittel H
Dtsch Med Wochenschr; 1979 Mar; 104(13):477-9. PubMed ID: 436602
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
17. [Isoprodiane therapy for previously untreated cavitating pulmonary tuberculosis (author's transl)].
Quinteros CM; Chehín E; Wayar E; Ratner M; Amadio G
Prax Klin Pneumol; 1979 Jan; 33(1):45-7. PubMed ID: 760101
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Kuz'min AV; Vasil'eva IA; Chernousova LN
Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
[TBL] [Abstract][Full Text] [Related]
19. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
Paramasivan CN; Chandrasekaran V; Santha T; Sudarsanam NM; Prabhakar R
Tuber Lung Dis; 1993 Feb; 74(1):23-7. PubMed ID: 8495016
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
Wipf R
Rev Med Suisse Romande; 1979 Apr; 99(4):205-13. PubMed ID: 504855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
